Literature DB >> 8957742

Insulin receptor content in tissues of normal and diabetic rats measured by radioimmunoassay.

V Pezzino1, A Costantino, P Russo, D Gullo, V Papa.   

Abstract

Insulin receptor (IR) content in different tissues has been quantitatively evaluated by means of steady state binding studies with radiolabeled insulin. The information provided by this approach, however, does not give a direct measurement of the receptor protein. Rather, it depends on the binding function of the IR, evaluated on the basis of curvilinear plots derived by Scatchard analysis of the experimental data. In the present report we employed a sensitive and specific radioimmunoassay (RIA) that allows a direct measurement of IR in solubilized cells or tissues. By this method we studied: a) IR distribution in several tissues of the rat, the animal model most frequently used in studies of insulin action; b) IR regulation in streptozotocin-treated, diabetic insulin deficient rats. Tissues from male Wistar rats (11 controls and 6 streptozotocin-treated diabetic animals) were homogenized, solubilized with Triton X-100 in the presence of protease inhibitors and stored at -80 C. IR content in the solubilized material was then measured by RIA. IR were detectable in all 11 tissues tested. Liver, kidney and brain neocortex had the highest IR content. (24.7 +/- 1.0, 20.5 +/- 1.1, 25.9 +/- 1.6 ng/mg protein, m +/- SE, respectively). As expected, circulating insulin levels were lower in diabetic rats than in control rats. In diabetic, insulin deficient rats, liver, kidney and skeletal muscle contained more IR than in control rats (p = 0.001; p = 0.018; p = 0.003, respectively), whereas IR content in neocortex was similar in the two groups. The IR RIA may represent a useful tool for the study of IR regulation and patho-physiology. Our data provide a comparative direct measurement of IR distribution in a variety of rat tissues. IR content in diabetic rats is increased in typical target organs for insulin action, as a consequence of up-regulation due to the reduced insulin levels. This is not the case for metabolically insulin-dependent tissues, like brain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957742     DOI: 10.1007/BF03349023

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  34 in total

1.  Insulin receptors are widely distributed in the central nervous system of the rat.

Authors:  J Havrankova; J Roth; M Brownstein
Journal:  Nature       Date:  1978-04-27       Impact factor: 49.962

2.  The nuclear envelope. The major site of insulin binding in rat liver nuclei.

Authors:  R Vigneri; I D Goldfine; K Y Wong; G J Smith; V Pezzino
Journal:  J Biol Chem       Date:  1978-04-10       Impact factor: 5.157

3.  Purification and characterization of the human brain insulin receptor.

Authors:  R A Roth; D O Morgan; J Beaudoin; V Sara
Journal:  J Biol Chem       Date:  1986-03-15       Impact factor: 5.157

4.  Human insulin receptor radioimmunoassay: applicability to insulin-resistant states.

Authors:  V Pezzino; V Papa; V Trischitta; A Brunetti; P A Goodman; M K Treutelaar; J A Williams; B A Maddux; R Vigneri; I D Goldfine
Journal:  Am J Physiol       Date:  1989-09

5.  Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization.

Authors:  B I Posner; P A Kelly; R P Shiu; H G Friesen
Journal:  Endocrinology       Date:  1974-08       Impact factor: 4.736

6.  Long-term maternal-fetal exposure to high-low insulin concentrations alter liver but not brain insulin receptors.

Authors:  S Devaskar; K McMenamy; L Holtzclaw; F Sadiq
Journal:  Am J Obstet Gynecol       Date:  1990-10       Impact factor: 8.661

7.  In vivo regulation of cell surface and intracellular insulin binding sites by insulin.

Authors:  R Vigneri; N B Pliam; D C Cohen; V Pezzino; K Y Wong; I D Goldfine
Journal:  J Biol Chem       Date:  1978-11-25       Impact factor: 5.157

8.  Functional properties of the subtype of insulin receptor found on neurons.

Authors:  K A Heidenreich; G de Vellis; P R Gilmore
Journal:  J Neurochem       Date:  1988-09       Impact factor: 5.372

9.  Insulin receptors in human circulating cells and fibroblasts.

Authors:  J R Gavin; J Roth; P Jen; P Freychet
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

10.  Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.

Authors:  J R Gavin; J Roth; D M Neville; P de Meyts; D N Buell
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

View more
  5 in total

1.  Reduced insulin-receptor mediated modulation of striatal dopamine release by basal insulin as a possible contributing factor to hyperdopaminergia in schizophrenia.

Authors:  Fernando Caravaggio; Margaret Hahn; Shinichiro Nakajima; Philip Gerretsen; Gary Remington; Ariel Graff-Guerrero
Journal:  Med Hypotheses       Date:  2015-06-24       Impact factor: 1.538

2.  Insulin-Dependent Maturation of Newly Generated Olfactory Sensory Neurons after Injury.

Authors:  Akihito Kuboki; Shu Kikuta; Nobuyoshi Otori; Hiromi Kojima; Ichiro Matsumoto; Johannes Reisert; Tatsuya Yamasoba
Journal:  eNeuro       Date:  2021-05-19

Review 3.  The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms.

Authors:  Kyong Hye Joung; Jae-Wook Jeong; Bon Jeong Ku
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

4.  Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences.

Authors:  Domenico Sergi; Justine Renaud; Nicola Simola; Maria-Grazia Martinoli
Journal:  Front Aging Neurosci       Date:  2019-11-08       Impact factor: 5.750

5.  Insulin-Induced Recurrent Hypoglycemia Up-Regulates Glucose Metabolism in the Brain Cortex of Chemically Induced Diabetic Rats.

Authors:  Susana Cardoso; Paula I Moreira
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.